PLAGL1 is associated with prognosis and cell proliferation in pancreatic adenocarcinoma

PLAGL1 is associated with prognosis and cell proliferation in pancreatic adenocarcinoma

Abstract Background Emerging evidence has shown the crucial roles of pleomorphic adenoma gene (PLAG) family genes in multiple cancers. However, their functions and mechanisms in pancreatic adenocarcinoma (PAAD) remain poorly understood. Methods We analyzed the expression levels of PLAG family genes...

Full description

Bibliographic Details
Main Authors:	Xing Liang, Zhiping Fu, Liang Tang, Minghui Zheng, Danlei Chen, Anan Liu, Ligang Shi, Linhua Yang, Chenghao Shao, Xiaoqiang Dong
Format:	Article
Language:	English
Published:	BMC 2023-01-01
Series:	BMC Gastroenterology
Subjects:	Pancreatic adenocarcinoma PLAGL1 Cell proliferation Prognostic biomarker Overall survival
Online Access:	https://doi.org/10.1186/s12876-022-02609-y

Similar Items

Overexpression of GATA5 Inhibits Prostate Cancer Progression by Regulating PLAGL2 via the FAK/PI3K/AKT Pathway
by: Qinghua Wang, et al.
Published: (2022-04-01)

CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas
by: Arnault Tauziède-Espariat, et al.
Published: (2024-04-01)

Transcription Factor PLAGL1 Is Associated with Angiogenic Gene Expression in the Placenta
by: Rebekah R. Starks, et al.
Published: (2020-11-01)

Circ-SOX4 drives the tumorigenesis and development of lung adenocarcinoma via sponging miR-1270 and modulating PLAGL2 to activate WNT signaling pathway
by: Nan Gao, et al.
Published: (2020-01-01)

Selenium sulfide disrupts the PLAGL2/C‐MET/STAT3‐induced resistance against mitochondrial apoptosis in hepatocellular carcinoma
by: Tianfeng Yang, et al.
Published: (2021-09-01)

Genomic Imprinting at the Porcine <i>PLAGL1</i> Locus and the Orthologous Locus in the Human
by: Jinsoo Ahn, et al.
Published: (2021-04-01)

Expression Profiles of Cuproptosis-Related Genes Determine Distinct Subtypes of Pancreatic Ductal Adenocarcinoma
by: Yusheng Chen, et al.
Published: (2023-01-01)

Polycomb protein RYBP activates transcription factor Plagl1 during in vitro cardiac differentiation of mouse embryonic stem cells
by: Surya Henry, et al.
Published: (2023-02-01)

A hierarchical prognostic model for Co-diabetes pancreatic adenocarcinoma
by: Zelong Wu, et al.
Published: (2023-11-01)

Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma
by: Wenjing Song, et al.
Published: (2021-06-01)

Resected pancreatic adenocarcinoma: An Asian institution's experience
by: Kennedy Yao Yi Ng, et al.
Published: (2021-10-01)

Identification of m7G-Related LncRNA Signature for Predicting Prognosis and Evaluating Tumor Immune Infiltration in Pancreatic Adenocarcinoma
by: Jiawei Lu, et al.
Published: (2023-05-01)

Rare Recurrent EWSR1-PLAGL1 Rearranged Intracranial Tumor With Biphasic Epithelioid Differentiation: One Case Report With Literature Review
by: Ai-yan Xing, et al.
Published: (2022-07-01)

Additive Value of Preoperative Sarcopenia and Lymphopenia for Prognosis Prediction in Localized Pancreatic Ductal Adenocarcinoma
by: Christelle d’Engremont, et al.
Published: (2021-05-01)

Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma
by: Shengbai Xue, et al.
Published: (2022-08-01)

The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression
by: Zhenze Zhao, et al.
Published: (2020-02-01)

FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma
by: Ugo Chianese, et al.
Published: (2023-01-01)

Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression
by: Liang Wang, et al.
Published: (2021-02-01)

PAC-5 Gene Expression Signature for Predicting Prognosis of Patients with Pancreatic Adenocarcinoma
by: Jieun Kim, et al.
Published: (2019-11-01)

Phosphomannose Isomerase High Expression Associated with Better Prognosis in Pancreatic Ductal Adenocarcinoma
by: Alipour Z, et al.
Published: (2021-09-01)

Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head
by: Chao Wu, et al.
Published: (2021-05-01)

Actin gamma 1 is a critical regulator of pancreatic ductal adenocarcinoma
by: Yichen Tang, et al.
Published: (2022-01-01)

An Automated Prognostic Model for Pancreatic Ductal Adenocarcinoma
by: Ioannis Vezakis, et al.
Published: (2023-08-01)

Construction and analysis of a novel ferroptosis‐related gene signature predicting prognosis in lung adenocarcinoma
by: Jing Zhou, et al.
Published: (2021-11-01)

Hyperdense Pancreatic Ductal Adenocarcinoma: Clinical Characteristics and Proteomic Landscape
by: He Xu, et al.
Published: (2021-02-01)

Identification of prognostic splicing factors and exploration of their potential regulatory mechanisms in pancreatic adenocarcinoma
by: Min-hua Rong, et al.
Published: (2020-02-01)

Metastatic pancreatic adenocarcinomas could be classified into M1a and M1b category by the number of metastatic organs
by: Fang Feng, et al.
Published: (2020-08-01)

A nomogram predicting overall survival in patients with non-metastatic pancreatic head adenocarcinoma after surgery: a population-based study
by: Wenbo Zou, et al.
Published: (2021-05-01)

Score for the Overall Survival Probability of Patients With Pancreatic Adenocarcinoma of the Body and Tail After Surgery: A Novel Nomogram-Based Risk Assessment
by: Chaobin He, et al.
Published: (2020-04-01)

Positive regulators of T cell proliferation as biomarkers for predicting prognosis and characterizing the immune landscape in lung adenocarcinoma
by: Yang Li, et al.
Published: (2022-11-01)

A Prognostic Survival Model of Pancreatic Adenocarcinoma Based on Metabolism-Related Gene Expression
by: Lin-ying Xie, et al.
Published: (2022-05-01)

PANoptosis-related long non-coding RNA signature to predict the prognosis and immune landscapes of pancreatic adenocarcinoma
by: Qinying Zhao, et al.
Published: (2024-03-01)

The Relationship between the Expression of GATA4 and GATA6 with the Clinical Characteristics and Prognosis of Resectable Pancreatic Adenocarcinoma
by: Victoria Heredia-Soto, et al.
Published: (2023-01-01)

Integrated analysis of necroptosis-related lncRNAs for prognosis and immunotherapy of patients with pancreatic adenocarcinoma
by: Jiantao Mo, et al.
Published: (2022-08-01)

GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma
by: Bo Liu, et al.
Published: (2021-05-01)

Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma
by: Zengyu Feng, et al.
Published: (2021-05-01)

Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis
by: Ke Zhang, et al.
Published: (2020-06-01)

Determination of a DNA repair-related gene signature with potential implications for prognosis and therapeutic response in pancreatic adenocarcinoma
by: Jinzhi Lai, et al.
Published: (2022-10-01)

Impact of Patient Age on Postoperative Short-Term and Long-Term Outcome after Pancreatic Resection of Pancreatic Ductal Adenocarcinoma
by: Danilo Hackner, et al.
Published: (2022-08-01)

Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma
by: Yingquan Ye, et al.
Published: (2022-09-01)